About Ingrid Olson

This author has not yet filled in any details.
So far Ingrid Olson has created 7 blog entries.

DE&I Champions: Maureen Hennessey

2022-09-08T15:11:16+00:00Events, Thought Leadership|

Congratulations to Maureen Hennessey for being named to the 2022 PharmaVoice100, as a DE&I Champion! Maureen has been fearless in her dedication and pursuit to address the gaps that exist in today’s healthcare system that lead to medication non-adherence and impact social determinants of health. She continues to inspire all of us by pushing the boundaries on what patient-centric care could and should be for all populations. Check out Maureen’s complete profile in PharmaVoice below: Congratulations to Maureen Hennessey for being named to the 2022 PharmaVoice100, as a DE&I Champion! Maureen has been fearless in her dedication and pursuit to address the gaps that exist in today’s healthcare system that lead to medication non-adherence and impact social determinants of health. She continues to inspire all of us by pushing the boundaries on what patient-centric care could and should be for all populations. Check out Maureen’s complete profile in PharmaVoice here!

New PRECISIONheor-led Study Examines Challenges in Capturing Economic Burden of Cancer

2022-08-26T02:53:15+00:00Events, Thought Leadership|

Congratulations to Suepattra May-Slater and the PRECISIONheor team for their contributions to a impactful study just published in the journal MMS Policy and Practice. The paper, entitled: “Estimating Productivity Loss from Breast and Non–Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method” outlines the challenges in truly capturing the economic burden of cancer for both patients and their caregivers.

Cell & Gene Day is August 24

2022-08-04T13:52:18+00:00Events, Thought Leadership|

As a wave of up-and-coming cell and gene therapies eye the path to approval soon, a combination of uncertainties threatens the waters ahead. A lack of talent, shortage of manufacturing, standardization, and shifting infrastructure are just the beginning of a range of potential issues.

Join Endpoints News and Precision ADVANCE for Cell & Gene Day, a free virtual event on August 24, from 12:00-4:00 PM ET where we convene three distinguished panels of experts to find out where the field stands today and explore funding, development and launch strategies to smooth out the ride to commercialization. You will hear from successful innovators from each facet of the CGTx landscape, including executives from Blackstone, Flagship Pioneering, Monograph Capital, Alliance for Regenerative Medicine, Satellite Bio, Cellevolve Bio, and more.

(more…)

NOW ON DEMAND – A Novel Data and Analytics-Informed Approach to Launch Excellence

2022-11-13T19:32:23+00:00Events, Thought Leadership|

Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.

Join Precision launch expert veterans for a live webinar discussion of the critical elements of a personalized, integrated and sustainable launch strategy.

  • Learn about key challenges to launch success
  • Understand how to de-risk and optimize commercial launch planning by better aligning efforts and managing expectations
  • Learn how integrating real-world data and innovative analytic models can better inform strategy and execution across stakeholders, for greater impact/effectiveness and efficiency

The discussion will conclude with a live Q&A.

WATCH ON DEMAND HERE!